Although polarized dermatoscopes yielded more reportable images and fewer quality issues, a lower-cost, ambient-light, nonpolarized dermatoscope provided comparable clinical utility at a fraction of the cost. https://t.co/G4vBIwT56J

Does offering multiple appropriate treatment alternatives affect the odds of primary care physicians choosing an alternative over the current care plan? A new RCT published today in @JAMANetworkOpen says YES. 🔗 https://t.co/ez0eP91bFt @GemmaAltinger @sydFMH_EMCR

Simple #design changes in EHR alerts, like presenting two or three good options instead of just one, could help #doctors provide #bettercare. But if these systems rely on outdated evidence, they risk doing more harm than good. #besci #medicine https://t.co/SPROfXandv

🔥New paper out today from PhD candidate @GemmaAltinger @msk_health Testing an old theory that giving two or more treatment options, e.g. in decision supports, causes indecision and suboptimal care. We found the opposite! Bravo Gemma! Open access: https://t.co/lHPuYeGTMu

🚨Out today in @JAMANetworkOpen! New trial involving 402 primary care physicians, found doctors who were offered two or more treatment alternatives were significantly more likely to choose a better option than those offered only one. https://t.co/SPROfXandv

Overdiagnosis not only causes harm to patients but distorts our understanding of disease, so-called knowledge harms https://t.co/fqzpiHeuVW @KatyJLBell @BMJ_EBM

Less is more for patients, practitioners, public and planet: a taxonomy for the harms of too much medicine via @KatyJLBell et al https://t.co/RCKHKHdefH

Very pleased and proud to see Public Health at the University of Sydney ranked #10 in the world. It's a wonderful community of passionate, committed teachers, researchers and practitioners who genuinely strive to make the world a better place. @jjaimemiranda

The November 2024 issue of The Health Advocate is live! 🌍💚 Featuring insights from the HEAL Network on climate action in healthcare, with strategies to reduce carbon footprints & build sustainable health systems. Check it out now! https://t.co/M8bkABx8kN

Clinical info for path Dx melanocytic skin lesions🔬 https://t.co/9OYk09sBLN Belinda Lai ℹ️ Clin Dx on path form⬇️odds of missing melanoma 🔍Clinical images (incl dermoscopic) ⬆️Dx certainty and pathologist agreement ↔️Dx usually; upgrades>downgrades ❓Impact on patient outcomes

Less is More for Greener ICUs! Interventions to decrease low-value care in ICU (e.g. unnecessary pathology and imaging) have important co-benefits for patient health (e.g.⬇️🩸transfusions), $, clinician time, and environmental impact💚 https://t.co/k0nZrT8iIS

Low-value care in #ICU 📚scoping review 🔎32 studies evaluating interventions to ⬇️ routine blood tests & CXRs +other types of low-value care 🩺💵🌱multiple evidence-based interventions may ⬇️ low-value care w health, financial, environmental co-benefits 🔓 https://t.co/huUTOpdMlH

Participant motivators & expectations in the MEL-SELF RCT of patient-led surveillance for recurrent melanoma: Content analysis of survey responses - @AckermannDee @KatyJLBell @getkarenbracken @MonikaJanda @choconz me https://t.co/hlg3eZH6hK @jmirpub @wiserhealthcare @HealthLitLab

Low and middle-income countries struggle to provide health care to some, while others get too much medicine. In this video, we delve into the research that addresses the stark disparities in healthcare provision in LMICs. https://t.co/iCb3F02t8q @Institute4EBH @wiserhealthcare

Preventing Overdiagnosis 2025 03 – 05 September 2025, Oxford, UK Call for Abstracts and Registration OPEN. https://t.co/RmokrGn3JM Too Much Medicine in in Low-and-Middle-Income Countries

Elle Macpherson's breast cancer revelation caused a stir this week. Shout out to @GuardianAus coverage from Melissa Davey & @natasha__may for https://t.co/matPkZ2Mpw . For more detail from health experts, proud to have commissioned this: https://t.co/QIpfW3iDuD

Elle Macpherson's breast cancer is non-invasive. That means her treatment - a lumpectomy - was actually "conventional", according to people who actually know about this stuff. Read more: https://t.co/4nypfUxH0V via @ConversationEDU

@bairdjulia @smh @theage At least one media outlet did interrogate the narrative. I commissioned and edited this piece

This is not the first time we’ve seen powerful celebrity stories about cancer have the potential to influence public health. Here's how you can make sense of the latest news. @Sydney_Uni